1. Review Nanoparticle targeting for generation of anti-tumor immunity.          
  2. Identify characteristics of tumor immune-microenvironment.
  3. Understand immunologic changes in patients receiving checkpoint blockade therapy.


Session date: 
07/28/2016 - 12:00pm to 1:00pm CDT
UCMC P-117
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kavita Dhodapkar, MD